IL155335A0 - Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament - Google Patents

Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament

Info

Publication number: IL155335A0
Authority: IL; Israel
Prior art keywords: medicament; producing; production; same; crystalline monohydrate
Prior art date: 2000-10-12

Application number

IL15533501A

Other languages

English (en)

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2001-09-28

Publication date

2003-11-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL155335(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-09-28 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-11-23 Publication of IL155335A0 publication Critical patent/IL155335A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IL15533501A 2000-10-12 2001-09-28 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament IL155335A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10050621		2000-10-12
PCT/EP2001/011225 WO2002030928A1 (de)	2000-10-12	2001-09-28	Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (1)

Publication Number	Publication Date
IL155335A0 true IL155335A0 (en)	2003-11-23

Family

ID=7659568

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15533501A IL155335A0 (en)	2000-10-12	2001-09-28	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
IL155335A IL155335A (en)	2000-10-12	2003-04-10	Crystalline monohydrate of tiotropium bromide, method for producing the same and the use thereof in the production of a medicament

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL155335A IL155335A (en)	2000-10-12	2003-04-10	Crystalline monohydrate of tiotropium bromide, method for producing the same and the use thereof in the production of a medicament

Country Status (46)

Country	Link
EP (2)	EP1468998A1 (sk)
JP (1)	JP3764422B2 (sk)
KR (1)	KR100823860B1 (sk)
CN (2)	CN1221549C (sk)
AP (1)	AP1572A (sk)
AR (2)	AR034389A1 (sk)
AT (1)	ATE276253T1 (sk)
AU (2)	AU2002214996B2 (sk)
BG (1)	BG66161B1 (sk)
BR (1)	BR0114584A (sk)
CA (1)	CA2425539C (sk)
CR (1)	CR6938A (sk)
CZ (1)	CZ301841B6 (sk)
DE (1)	DE50103666D1 (sk)
DK (1)	DK1326862T3 (sk)
DZ (1)	DZ3478A1 (sk)
EA (1)	EA004381B1 (sk)
EC (1)	ECSP034540A (sk)
EE (1)	EE04567B1 (sk)
EG (1)	EG24142A (sk)
ES (1)	ES2228965T3 (sk)
GE (1)	GEP20063905B (sk)
HR (1)	HRP20030276B1 (sk)
HU (1)	HU226830B1 (sk)
IL (2)	IL155335A0 (sk)
IS (1)	IS2339B (sk)
MA (1)	MA25842A1 (sk)
ME (2)	ME00243B (sk)
MX (1)	MXPA03003221A (sk)
MY (1)	MY126931A (sk)
NO (1)	NO328465B1 (sk)
NZ (1)	NZ525733A (sk)
OA (1)	OA12403A (sk)
PE (1)	PE20020422A1 (sk)
PL (1)	PL207870B1 (sk)
PT (1)	PT1326862E (sk)
RS (1)	RS50218B (sk)
SA (1)	SA01220412B1 (sk)
SI (1)	SI1326862T1 (sk)
SK (1)	SK287009B6 (sk)
TR (1)	TR200402579T4 (sk)
TW (1)	TW589313B (sk)
UA (1)	UA74215C2 (sk)
UY (2)	UY26962A1 (sk)
WO (1)	WO2002030928A1 (sk)
ZA (1)	ZA200302500B (sk)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6608055B2 (en)	2001-06-22	2003-08-19	Boehringer Ingelheim Pharma Kg	Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
EP1401445B1 (de) *	2001-06-22	2006-08-23	Boehringer Ingelheim Pharma GmbH & Co.KG	Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE10212264A1 (de)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7244415B2 (en)	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
US7311894B2 (en)	2002-03-28	2007-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations containing an anticholinergic
DE10214263A1 (de) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
DK1682541T3 (da) *	2003-11-03	2010-06-28	Boehringer Ingelheim Int	Fremgangsmåde til fremstilling af tiotropiumsalte
US7968717B2 (en)	2003-11-03	2011-06-28	Boehringer Ingelhein International Gmbh	Crystalline anhydrate with anticholinergic efficacy
DE502004010602D1 (de) *	2003-11-03	2010-02-11	Boehringer Ingelheim Pharma	Neues kristallines anhydrat mit anticholinerger wirksamkeit
JP5165245B2 (ja) *	2003-11-03	2013-03-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規なチオトロピウム塩、その製造方法及びチオトロピウム塩を含有する医薬組成物
DE102004016179A1 (de) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von proliferativen Prozessen
PL2422786T3 (pl)	2004-04-22	2015-02-27	Boehringer Ingelheim Int	Nowe kombinacje środków leczniczych do leczenia chorób dróg oddechowych
DE102004024454A1 (de)	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ATE427108T1 (de)	2004-08-11	2009-04-15	Boehringer Ingelheim Pharma	Anticholinergika enthaltende arzneimittel zur behandlung von krankheiten der ableitenden harnwege
US20060079544A1 (en) *	2004-08-13	2006-04-13	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
WO2006045715A1 (de) *	2004-10-21	2006-05-04	Boehringer Ingelheim International Gmbh	Blister für inhalatoren
EP1858554A2 (en) *	2005-03-09	2007-11-28	Boehringer Ingelheim International GmbH	New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
AU2006239389B2 (en)	2005-04-28	2012-06-28	Boehringer Ingelheim International Gmbh	Novel compounds for treating inflammatory diseases
RU2007144531A (ru) *	2005-05-02	2009-06-10	БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)	Новые кристаллические формы тиотропийбромида
RU2417224C2 (ru)	2005-05-02	2011-04-27	Бёрингер Ингельхайм Интернациональ Гмбх	Новые кристаллические формы тиотропийбромида
MX2007015997A (es) *	2005-06-15	2008-03-07	Boehringer Ingelheim Int	Procedimiento para preparar nuevas sales de tiotropio, nuevas sales de tiotropio como tales y composiciones farmaceuticas de las mismas.
DE102005030733A1 (de)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
EP1915158A1 (en) *	2005-08-06	2008-04-30	Boehringer Ingelheim International GmbH	Use of tiotropium salts in the treatment of severe persistant asthma
KR101360803B1 (ko)	2005-08-15	2014-02-11	베링거 인겔하임 인터내셔날 게엠베하	베타모방제의 제조방법
US20070086957A1 (en) *	2005-10-10	2007-04-19	Thierry Bouyssou	Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en)	2005-11-09	2008-09-09	Boehringer Ingelheim International Gmbh	Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de)	2005-12-14	2007-06-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Mikronisierung
EP1966196A2 (en) *	2005-12-19	2008-09-10	Sicor, Inc.	Pure and stable tiotropium bromide
BRPI0608427A2 (pt) *	2005-12-19	2009-12-29	Sicor Inc	novas formas de brometo de tiotrópio e processos para seu preparo
PT1971332E (pt) *	2006-01-04	2011-03-18	Boehringer Ingelheim Int	Utilização de sais de tiotrópio no tratamento da asma moderada persistente
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
MX2007012313A (es)	2006-04-19	2007-11-21	Boehringer Ingelheim Int	Dihidrotienopirimidinas para el tratamiento de enfermedades inflamatorias.
US20080051582A1 (en)	2006-07-10	2008-02-28	Sicor Inc.	Process for the preparation of tiotropium bromide
CA2660186A1 (en)	2006-08-07	2008-02-14	Boehringer Ingelheim International Gmbh	Pharmaceutical combinations for the treatment of respiratory diseases
PE20080610A1 (es)	2006-08-22	2008-07-15	Boehringer Ingelheim Int	Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
EP1923393A1 (en) *	2006-11-17	2008-05-21	Boehringer Ingelheim Pharma GmbH & Co. KG	Crystalline form of tiotropium bromide and urea
EP1925295A1 (de)	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Stabile Pulverformulierung enthaltend ein Anticholinergikum
GB0716026D0 (en) *	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
PT2215092E (pt)	2007-10-19	2012-04-10	Boehringer Ingelheim Int	Piperidino-di-hidrotienopirimidinas substituídas
EP2093219A1 (de)	2008-02-22	2009-08-26	Boehringer Ingelheim International Gmbh	Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
US20100272811A1 (en) *	2008-07-23	2010-10-28	Alkermes,Inc.	Complex of trospium and pharmaceutical compositions thereof
CN102256963B (zh)	2008-12-19	2014-06-11	贝林格尔.英格海姆国际有限公司	作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
EP2201934A1 (en)	2008-12-23	2010-06-30	CHIESI FARMACEUTICI S.p.A.	Tiotropium aerosol formulation products with improved chemical stability
EP2403851B1 (en)	2009-03-06	2015-06-17	Mahmut Bilgic	New crystalline forms of tiotropium bromide
WO2011015883A1 (en)	2009-08-07	2011-02-10	Generics [Uk] Limited	Dichloromethane solvate of tiotropium bromide and its use
JP5822831B2 (ja)	2009-08-07	2015-11-24	ジェネリクス・［ユーケー］・リミテッド	チオトロピウム臭化物の無水物
US20130143905A1 (en)	2009-12-17	2013-06-06	Boehringer Ingelheim International Gmbh	Novel antagonists for ccr2 and uses thereof
PL2513093T3 (pl)	2009-12-17	2015-03-31	Centrexion Therapeutics Corp	Nowi antagoniści receptora CCR2 i ich zastosowanie
BR112012018865A2 (pt)	2010-01-29	2016-04-12	Boehringer Ingelheim Int	naftiridinas substituídas e seu uso como inibidores de quinase syk
JP2013526507A (ja)	2010-05-12	2013-06-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
WO2011141477A1 (en)	2010-05-12	2011-11-17	Boehringer Ingelheim International Gmbh	New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP5647339B2 (ja)	2010-05-17	2014-12-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ２アンタゴニスト及びこれらの使用
WO2011147772A1 (en)	2010-05-25	2011-12-01	Boehringer Ingelheim International Gmbh	Ccr2 receptor antagonists
JP5721242B2 (ja)	2010-06-01	2015-05-20	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２アンタゴニスト
JP5959537B2 (ja)	2011-01-28	2016-08-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	置換ピリジニル−ピリミジン及び医薬としてのその使用
TR201102068A2 (tr) *	2011-03-03	2012-09-21	Bi̇lgi̇ç Mahmut	Tiotropyum bromür içeren kristal maddeler
WO2012171863A1 (en)	2011-06-16	2012-12-20	Boehringer Ingelheim International Gmbh	New selective ccr2 antagonists
EP2731941B1 (en)	2011-07-15	2019-05-08	Boehringer Ingelheim International GmbH	Novel and selective ccr2 antagonists
JP5860960B2 (ja)	2011-07-26	2016-02-16	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	置換キノリン類及び医薬としてのそれらの使用
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs) *	2011-11-28	2014-04-02	Zentiva, K.S.	Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
US9096579B2 (en)	2012-04-20	2015-08-04	Boehringer Ingelheim International Gmbh	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
ME02679B (me)	2012-11-05	2017-06-20	Zentiva Ks	Stabilizacija tiotropij solvata
EP2913332A1 (en) *	2014-02-27	2015-09-02	Euticals S.P.A.	Crystalline form of tiotropium bromide with lactose
WO2015140051A1 (en)	2014-03-19	2015-09-24	Boehringer Ingelheim International Gmbh	Heteroaryl sik inhibitors
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
RU2567539C1 (ru) *	2015-02-04	2015-11-10	Индивидуальный предприниматель Михайлов Олег Ростиславович	КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
WO2017138896A1 (en)	2016-02-11	2017-08-17	Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti	Crystalline form of tiotropium bromide anhydrate
EP3430011A4 (en) *	2016-11-04	2019-08-14	Sima Patent Ve Lisanslama Hizmetleri Ltd. STI	NOVEL ACTIVE SUBSTANCE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (de) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
WO1994013263A1 (en) *	1992-12-09	1994-06-23	Jager Paul D	Stabilized medicinal aerosol solution formulations
DE19834506A1 (de) *	1998-07-31	2000-02-03	Hexal Ag	Transmucosales therapeutisches System zur Anwendung von Sildenafil
CA2338680C (en) *	1998-08-04	2008-10-14	Jago Research Ag	Medicinal aerosol formulations

2001
- 2001-09-28 PL PL366041A patent/PL207870B1/pl unknown
- 2001-09-28 RS YU27303A patent/RS50218B/sr unknown
- 2001-09-28 MX MXPA03003221A patent/MXPA03003221A/es active IP Right Grant
- 2001-09-28 ME MEP-2008-400A patent/ME00243B/me unknown
- 2001-09-28 AT AT01983510T patent/ATE276253T1/de active
- 2001-09-28 CA CA002425539A patent/CA2425539C/en not_active Expired - Lifetime
- 2001-09-28 BR BR0114584-3A patent/BR0114584A/pt not_active Application Discontinuation
- 2001-09-28 SI SI200130219T patent/SI1326862T1/xx unknown
- 2001-09-28 AU AU2002214996A patent/AU2002214996B2/en not_active Expired
- 2001-09-28 GE GE5214A patent/GEP20063905B/en unknown
- 2001-09-28 DK DK01983510T patent/DK1326862T3/da active
- 2001-09-28 CN CNB018171435A patent/CN1221549C/zh not_active Ceased
- 2001-09-28 CN CNB2005100977370A patent/CN100519558C/zh not_active Ceased
- 2001-09-28 UA UA2003054185A patent/UA74215C2/uk unknown
- 2001-09-28 HR HR20030276A patent/HRP20030276B1/xx not_active IP Right Cessation
- 2001-09-28 OA OA1200300107A patent/OA12403A/fr unknown
- 2001-09-28 CZ CZ20031025A patent/CZ301841B6/cs not_active IP Right Cessation
- 2001-09-28 ES ES01983510T patent/ES2228965T3/es not_active Expired - Lifetime
- 2001-09-28 PT PT01983510T patent/PT1326862E/pt unknown
- 2001-09-28 AP APAP/P/2003/002775A patent/AP1572A/en active
- 2001-09-28 NZ NZ525733A patent/NZ525733A/en not_active IP Right Cessation
- 2001-09-28 EP EP04016877A patent/EP1468998A1/de not_active Withdrawn
- 2001-09-28 DZ DZ013478A patent/DZ3478A1/fr active
- 2001-09-28 SK SK436-2003A patent/SK287009B6/sk not_active IP Right Cessation
- 2001-09-28 TR TR2004/02579T patent/TR200402579T4/xx unknown
- 2001-09-28 KR KR1020037005083A patent/KR100823860B1/ko not_active Expired - Lifetime
- 2001-09-28 ME MEP-400/08A patent/MEP40008A/xx unknown
- 2001-09-28 WO PCT/EP2001/011225 patent/WO2002030928A1/de not_active Ceased
- 2001-09-28 IL IL15533501A patent/IL155335A0/xx active IP Right Grant
- 2001-09-28 JP JP2002534314A patent/JP3764422B2/ja not_active Expired - Lifetime
- 2001-09-28 HU HU0301022A patent/HU226830B1/hu unknown
- 2001-09-28 EP EP01983510A patent/EP1326862B1/de not_active Expired - Lifetime
- 2001-09-28 EA EA200300457A patent/EA004381B1/ru not_active IP Right Cessation
- 2001-09-28 EE EEP200300171A patent/EE04567B1/xx unknown
- 2001-09-28 DE DE50103666T patent/DE50103666D1/de not_active Expired - Lifetime
- 2001-09-28 AU AU1499602A patent/AU1499602A/xx active Pending
- 2001-10-02 SA SA01220412A patent/SA01220412B1/ar unknown
- 2001-10-09 EG EG20011058A patent/EG24142A/xx active
- 2001-10-09 TW TW090124963A patent/TW589313B/zh active
- 2001-10-10 UY UY26962A patent/UY26962A1/es not_active Application Discontinuation
- 2001-10-10 MY MYPI20014705A patent/MY126931A/en unknown
- 2001-10-10 PE PE2001001000A patent/PE20020422A1/es active IP Right Grant
- 2001-10-12 AR ARP010104782A patent/AR034389A1/es active IP Right Grant
2003
- 2003-03-26 CR CR6938A patent/CR6938A/es unknown
- 2003-03-28 BG BG107687A patent/BG66161B1/bg unknown
- 2003-03-31 ZA ZA200302500A patent/ZA200302500B/en unknown
- 2003-04-07 EC EC2003004540A patent/ECSP034540A/es unknown
- 2003-04-08 MA MA27102A patent/MA25842A1/fr unknown
- 2003-04-09 IS IS6772A patent/IS2339B/is unknown
- 2003-04-10 IL IL155335A patent/IL155335A/en unknown
- 2003-04-11 NO NO20031694A patent/NO328465B1/no not_active IP Right Cessation
2008
- 2008-09-19 AR ARP080104109A patent/AR068527A2/es unknown
2013
- 2013-07-11 UY UY34901A patent/UY34901A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20030042008A (ko)	2003-05-27
SK287009B6 (sk)	2009-09-07
YU27303A (sh)	2006-05-25
AR068527A2 (es)	2009-11-18
NO20031694D0 (no)	2003-04-11
BG107687A (bg)	2003-09-30
TW589313B (en)	2004-06-01
CN100519558C (zh)	2009-07-29
AU2002214996B2 (en)	2007-03-15
IL155335A (en)	2009-02-11
NZ525733A (en)	2005-01-28
PT1326862E (pt)	2004-11-30
WO2002030928A1 (de)	2002-04-18
ATE276253T1 (de)	2004-10-15
BR0114584A (pt)	2003-08-26
KR100823860B1 (ko)	2008-04-21
HUP0301022A2 (hu)	2003-10-28
TR200402579T4 (tr)	2004-12-21
ZA200302500B (en)	2004-04-22
HRP20030276B1 (en)	2006-02-28
DE50103666D1 (de)	2004-10-21
SI1326862T1 (sl)	2005-02-28
AU1499602A (en)	2002-04-22
AR034389A1 (es)	2004-02-25
AP1572A (en)	2006-02-13
RS50218B (sr)	2009-07-15
MA25842A1 (fr)	2003-07-01
EP1326862B1 (de)	2004-09-15
NO20031694L (no)	2003-04-11
PL366041A1 (en)	2005-01-24
CZ301841B6 (cs)	2010-07-07
IS2339B (is)	2008-02-15
HRP20030276A2 (en)	2005-02-28
JP2004526668A (ja)	2004-09-02
CN1733761A (zh)	2006-02-15
JP3764422B2 (ja)	2006-04-05
CA2425539A1 (en)	2003-04-11
CN1469877A (zh)	2004-01-21
HUP0301022A3 (en)	2005-12-28
EA004381B1 (ru)	2004-04-29
ECSP034540A (es)	2003-07-25
EP1326862A1 (de)	2003-07-16
EP1468998A1 (de)	2004-10-20
ES2228965T3 (es)	2005-04-16
HU226830B1 (en)	2009-11-30
UY26962A1 (es)	2002-06-20
CR6938A (es)	2004-10-28
PE20020422A1 (es)	2002-06-28
MXPA03003221A (es)	2004-12-03
MEP40008A (en)	2011-02-10
PL207870B1 (pl)	2011-02-28
HK1086557A1 (zh)	2006-09-22
GEP20063905B (en)	2006-08-25
SA01220412B1 (ar)	2006-11-05
DZ3478A1 (fr)	2002-04-18
MY126931A (en)	2006-10-31
UY34901A (es)	2015-02-27
EG24142A (en)	2008-08-06
IS6772A (is)	2003-04-09
NO328465B1 (no)	2010-02-22
UA74215C2 (uk)	2005-11-15
DK1326862T3 (da)	2004-11-22
ME00243B (me)	2011-05-10
EA200300457A1 (ru)	2003-10-30
CA2425539C (en)	2007-04-03
EE04567B1 (et)	2005-12-15
AP2003002775A0 (en)	2003-03-31
HK1060567A1 (en)	2004-08-13
OA12403A (en)	2006-04-18
CN1221549C (zh)	2005-10-05
EE200300171A (et)	2003-06-16
BG66161B1 (bg)	2011-09-30
SK4362003A3 (en)	2003-08-05

Publication	Publication Date	Title
IL155335A0 (en)	2003-11-23	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
AU2002214996A1 (en)	2002-06-27	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
HRP20031066A2 (en)	2004-04-30	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
AU2002345016A1 (en)	2003-06-19	Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
IL153273A0 (en)	2003-07-06	Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
AU2001262318A1 (en)	2002-03-07	Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
HUP0105148A3 (en)	2003-01-28	Telmisartan polymorph, method for producing same and its use in the preparation of a medicament
HUP0300327A3 (en)	2004-10-28	Percyquinnin, a process for its production and its use as a pharmaceutical
GB2347938B (en)	2001-07-11	Production method for hydrate and device for producing the same
AU2002255321A2 (en)	2003-07-10	Tablets quickly disintegrating in the oral cavity and process for producing the same
AU2002255321A1 (en)	2003-05-01	Tablets quickly disintegrating in the oral cavity and process for producing the same
TWI345975B (en)	2011-08-01	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
AU2002213975A1 (en)	2002-07-04	Novel anticholinergic agents that can be used as medicaments and method for the production thereof
IL160440A (en)	2009-09-01	Dihydropteridinones, method for producing the same and the use thereof as medicaments
EP1216621A4 (en)	2004-05-26	SOFT SWEETS AND METHOD FOR THE PRODUCTION THEREOF
PL369889A1 (en)	2005-05-02	Anticholinergic agents, method for producing the same and use thereof as medicaments
AU3162001A (en)	2001-07-03	Medicament, a method for its production and the use thereof
HUP0302099A3 (en)	2009-08-28	Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form
TWI318211B (en)	2009-12-11	Novel derivatives of 4a, 5, 9, 10, 11, 12-hexahydrobenzofuro [3a, 2, 2] [2] -benzazepine, method for the production thereof and use thereof in the production of medicaments
ZA200500526B (en)	2006-08-30	Prodrug, medicinal utilization thereof and process for producing the same
HUP0300306A3 (en)	2004-10-28	Cyclipostins, a method for their production and the use of the same
HU0001417D0 (en)	2000-06-28	New pharmaceutically applicable salts, process for their production and medicaments containing them
EP1310503A4 (en)	2005-10-05	PROCESS FOR THE PRODUCTION OF HYDRAZINOMONOSACCHARIDE DERIVATIVES AND THEIR USE
HUP0302989A3 (en)	2007-06-28	Benzamidine derivatives and process for production thereof
AU2795202A (en)	2002-06-18	Klainetin and derivatives thereof, method for their production and the use of the same

Legal Events

Date	Code	Title	Description
2009-12-24	FF	Patent granted
2009-12-24	KB	Patent renewed